Lymphoma Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

For Hodgkin Lymphoma (HL) Survivors:

• People who were treated for Hodgkin Lymphoma at St. Jude Children's Research Hospital and received bleomycin (a chemotherapy drug) and/or radiation to the chest area as part of that treatment.
• People who were under 21 years old when they were diagnosed, are now at least 18 years old, and finished treatment at least 2 years ago.
• People who are already enrolled in the SJLIFE or ACT/SJLIFE research programs at St. Jude.
• People who are proficient in English.

For Community Controls (comparison group participants):

• People who are already part of the SJLIFE control group.
• People who are at least 18 years old at the time of joining, with ages selected to broadly match those of the HL survivors in the study.

Who may not be able to join:

For Hodgkin Lymphoma Survivors:

• People who received radiation directed at the head or to the entire body as part of their cancer treatment.
• People who received certain chemotherapy drugs delivered directly into the spine or received high doses of certain chemotherapy drugs through an IV (confirm with trial site).
• People who have had a significant head injury or have been diagnosed with a genetic condition known to affect thinking, memory, or learning.

Important: Always verify eligibility with the trial site directly before applying.